Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (191-200 of 365) with videos related to

Pageof 37
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 13, 2026
Combined HBsAg and anti-HBc testing is required to estimate hepatitis B virus seroprevalence in a low-endemic country: findings from a nationwide population-based serosurvey, Belgium, 2020Arno Furquim d'Almeida, Erwin Ho, Christian Schüttler, et al.
Vaccine|July 2, 2011
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trialsPierre Van Damme, Peter McIntyre, Emmanuel Grimprel, et al.
Vaccines|July 27, 2024
Primary Healthcare Providers' Views on Periodic COVID-19 Booster Vaccination for Themselves and Their Patients: A 2023 Nationwide Survey in BelgiumMarina Digregorio, Pauline Van Ngoc, Julie Domen, et al.
Human Vaccines & Immunotherapeutics|May 14, 2015
Coverage of the expanded program on immunization in Vietnam: Results from 2 cluster surveys and routine reportsTrung Dac Nguyen, Anh Duc Dang, Pierre Van Damme, et al.
Vaccine|December 5, 2021
Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020)Sara Valckx, Jonas Crèvecoeur, Frederik Verelst, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2016
Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income CountriesAjoke Sobanjo-Ter Meulen, Philippe Duclos, Peter McIntyre, et al.
Biometrical Journal. Biometrische Zeitschrift|July 12, 2022
A spatial model to jointly analyze self-reported survey data of COVID-19 symptoms and official COVID-19 incidence dataMaren Vranckx, Christel Faes, Geert Molenberghs, et al.
Human Vaccines & Immunotherapeutics|December 23, 2014
Assessment of acceptability and usability of new delivery prototype device for intradermal vaccination in healthy subjectsTimothi J S Van Mulder, Stijn Verwulgen, Koen C L Beyers, et al.
Vaccine|November 29, 2017
Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programmeIne Wouters, Liesbet Van Heirstraeten, Stefanie Desmet, et al.
Scandinavian Journal of Infectious Diseases|August 17, 2004
The prevalence of the human papillomavirus in cervix and vagina in low-risk and high-risk populationsMarc Baay, Veronique Verhoeven, Kristien Wouters, et al.
Pageof 37

Showing results (191-200 of 365) with videos related to

Sort By:
Pageof 37
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 13, 2026
Combined HBsAg and anti-HBc testing is required to estimate hepatitis B virus seroprevalence in a low-endemic country: findings from a nationwide population-based serosurvey, Belgium, 2020Arno Furquim d'Almeida, Erwin Ho, Christian Schüttler, et al.
Vaccine|July 2, 2011
Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trialsPierre Van Damme, Peter McIntyre, Emmanuel Grimprel, et al.
Vaccines|July 27, 2024
Primary Healthcare Providers' Views on Periodic COVID-19 Booster Vaccination for Themselves and Their Patients: A 2023 Nationwide Survey in BelgiumMarina Digregorio, Pauline Van Ngoc, Julie Domen, et al.
Human Vaccines & Immunotherapeutics|May 14, 2015
Coverage of the expanded program on immunization in Vietnam: Results from 2 cluster surveys and routine reportsTrung Dac Nguyen, Anh Duc Dang, Pierre Van Damme, et al.
Vaccine|December 5, 2021
Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July-December 2020)Sara Valckx, Jonas Crèvecoeur, Frederik Verelst, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2016
Assessing the Evidence for Maternal Pertussis Immunization: A Report From the Bill & Melinda Gates Foundation Symposium on Pertussis Infant Disease Burden in Low- and Lower-Middle-Income CountriesAjoke Sobanjo-Ter Meulen, Philippe Duclos, Peter McIntyre, et al.
Biometrical Journal. Biometrische Zeitschrift|July 12, 2022
A spatial model to jointly analyze self-reported survey data of COVID-19 symptoms and official COVID-19 incidence dataMaren Vranckx, Christel Faes, Geert Molenberghs, et al.
Human Vaccines & Immunotherapeutics|December 23, 2014
Assessment of acceptability and usability of new delivery prototype device for intradermal vaccination in healthy subjectsTimothi J S Van Mulder, Stijn Verwulgen, Koen C L Beyers, et al.
Vaccine|November 29, 2017
Nasopharyngeal s. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programmeIne Wouters, Liesbet Van Heirstraeten, Stefanie Desmet, et al.
Scandinavian Journal of Infectious Diseases|August 17, 2004
The prevalence of the human papillomavirus in cervix and vagina in low-risk and high-risk populationsMarc Baay, Veronique Verhoeven, Kristien Wouters, et al.
Pageof 37